News und Analysen
Simulations Plus Acquires Lixoft, Expanding Modeling Software Offerings and Broadening Presence in Europe
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has acquired Lixoft of Paris
Dexcom Schedules First Quarter 2020 Earnings Release and Conference Call for April 28, 2020 at 4:30 p.m. Eastern Time
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2020 financial results after market close on Tuesday, April 28, 2020. Management will hold a conference call to
Free Remote Monitoring Solution Now Available for All Clinical Research Sites
Veeva Systems (NYSE: VEEV) today announced new remote monitoring capabilities in Veeva SiteVault Free for source document review and verification in clinical trials. Veeva SiteVault Free gives
Premier Inc. Survey: As COVID-19 Spreads to New Hotspots, Hospitals Should Prepare for up to a 17X Surge in Supply Demand
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results quantifying the surge capacity needed for personal protective equipment (PPE) and other supplies
Premier Inc. Data Shows Drugs Essential to Providing Care for COVID-19 Patients Quickly Slipping into Shortage
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released data finding that 15 drugs essential to providing care for COVID-19 patients are currently in or very near
Agilent Introduces New Handheld Raw Material ID System for Pharmaceutical Manufacturers
Agilent Technologies Inc. (NYSE: A) today announced the launch of the newest instrument in its Raman technology portfolio. The new Agilent Vaya Raman raw material identity verification system is a
Good News bei... Eckert & Ziegler: Rekordgewinn, Dividendenerhöhung und ein Aktiensplit
Agilent Technologies to Change Location of Annual Meeting
Agilent Technologies, Inc. (NYSE: A) today filed a supplement to its proxy statement with the Securities and Exchange Commission announcing a change of location for its previously adjourned annual
LivaNova to Host Conference Call for First Quarter 2020 Results
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first quarter 2020 results on Wednesday, April 29, 2020 at 1 p.m
Agilent Announces New Class 1 Triple Quadrupole LC/MS System
Agilent Technologies Inc. (NYSE: A) today introduced the Agilent K6460S Clinical Edition TQ LC/MS system, designed to improve in vitro diagnostic workflows in clinical labs.
Agilent’s
Drägerwerk: Aktie dank Nachfrageboom im Höhenflug
Drägerwerk (WKN: 555060) erlebt eine Sonderkonjunktur durch die weltweite Ausbreitung des Coronavirus. Die Aktie klettert heute +8,01% auf 95,75 Euro.
Dass die Medizinprodukte jetzt „mehr gebraucht
Simulations Plus Offers Rapid Response COVID-19 Research Initiative
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced the
Humana Works to Increase Capacity for Coronavirus Treatment
To prepare for the influx of patients who will need to be treated for coronavirus (COVID-19), Humana Inc. (NYSE: HUM) is taking steps to make it easier for members and health systems. Specifically
LivaNova Autonomic Regulation Therapy for Heart Failure Findings to be Presented at American College of Cardiology and World Congress of Cardiology Virtual Meeting
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced two abstracts focused on implantable neuromodulation technology for patients with heart
Veeva Data Cloud to Deliver New Approach for Patient and Prescriber Data
Veeva Systems (NYSE: VEEV) today announced Veeva Data Cloud to help support the industry by bringing greater innovation and choice to the data market. Veeva Data Cloud will include longitudinal
Quidel’s Lyra® SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19; Also Receives CE Mark, Health Canada Authorization
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel’s Lyra®
Drägerwerk: Jetzt mischt Elon Musk mit!
Drägerwerk (WKN: 555060) fertigt die in der Corona-Pandemie in Krankenhäusern so dringend benötigten Beatmungsgeräte. Dazu gab es jüngst einen Großauftrag von der Bundesregierung über 10.000 Geräte
MEDICREA Is Protected From the Consequences of the COVID-19 Pandemic
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
Agilent Technologies Announces Cash Dividend of 18 Cents Per Share
Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 18 cents per share of common stock will be paid on April 22, 2020, to all shareholders of record as of the close of
Sandra Suarez-Sharp Joins Simulations Plus to Lead Regulatory Strategies Team
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that
Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assay
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has
Agilent Technologies to Adjourn Annual Meeting Until April 17, 2020
Agilent Technologies, Inc. (NYSE: A) today announced plans to adjourn its annual meeting of stockholders, originally scheduled to be held March 18, 2020, due to public health considerations
Humana Foundation Donates $500,000 in Support of Coronavirus Pandemic Relief and Recovery Efforts
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM), announced today it will provide $500,000 in support of coronavirus (COVID-19) relief and recovery efforts, partnering with three
American Renal Associates Holdings, Inc. Announces Fourth Quarter 2019 Results
American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and
Drägerwerk: Die Bundesregierung redet ein großes Wörtchen mit!
Es war der nächste schwarze Montag an den Börsen – eine der ganz wenigen Ausnahmeerscheinungen ist die Aktie von Drägerwerk (WKN: 555060). Der unscheinbare Titel aus dem SDAX ging heute mit einem